Skip to content

Medical emergency? What to do

Genomic Health says Medicare to cover cancer test

3-RXPublished January 14, 20061 min read

Key points

  • Genomic Health Inc. said on Friday that Medicare has agreed to cover the company's test for determining whether a woman with early breast cancer is likely to be helped by chemotherapy, sending the company's shares up as much as 35 percent.
  • Genomic Health said National Heritage Insurance Co., the contractor that administers Medicare programs in California, has established a positive coverage policy for the Oncotype DX breast cancer test.
  • The coverage is scheduled to become effective for claims for services performed on or after Feb.
  • The 125,000 women diagnosed each year with estrogen-sensitive tumors whose cancer has not spread to the lymph nodes are candidates for using the test, which can identify which tumors are likely to recur after surgery and treatment with hormonal drugs.

Genomic Health Inc. said on Friday that Medicare has agreed to cover the company's test for determining whether a woman with early breast cancer is likely to be helped by chemotherapy, sending the company's shares up as much as 35 percent.

Genomic rose $2.46, or 25 percent, to $12.41 on Nasdaq at mid-afternoon.

Genomic Health said National Heritage Insurance Co., the contractor that administers Medicare programs in California, has established a positive coverage policy for the Oncotype DX breast cancer test.

All Medicare claims for the test are currently billed through NHIC because the test is conducted by Genomic Health in its Redwood City, California, clinical reference laboratory.

The coverage is scheduled to become effective for claims for services performed on or after Feb. 27, the company said.

The $3,400 test, launched in 2004, was used by about 5,000 patients in the first nine months of last year, compared with 500 in its first year on the market, Chief Executive Randy Scott said earlier this week.

The 125,000 women diagnosed each year with estrogen-sensitive tumors whose cancer has not spread to the lymph nodes are candidates for using the test, which can identify which tumors are likely to recur after surgery and treatment with hormonal drugs.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underCancer

Keep reading

Brain

Italy court ruling links mobile phone use to tumor

Italy's supreme court has upheld a ruling that said there was a link between a business executive's brain tumor and his heavy mobile phone usage, potentially opening the door to further legal claims. The court's…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.